Chipcytometry in a clinical setting
-
Upload
jan-detmers -
Category
Technology
-
view
272 -
download
1
Transcript of Chipcytometry in a clinical setting
![Page 1: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/1.jpg)
ChipCytometry
Welcome!
![Page 2: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/2.jpg)
Agenda
2
• 10:30 Arrival at Peter Medawar Building for Pathogen Research • 10:45 Chris Willberg: Welcome reception, introduction • 11:15 Christian Hennig: Introduction to Chipcytometry, Deep
Phenotyping and Tissue Cytometry • 11:45 Matthew Bilton: Analysis of MAIT cell populations within
mediastinal lymph nodes. • 12:15 Jan Detmers: Chipcytometry in a clinical setting • 12:30 Lunch • 13:15 visiting the lab • 14:00 Christian Hennig: Chipcytometry case studies, Q&A • 15:30 End of meeting
![Page 3: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/3.jpg)
About
3
Zellkraftwerk GmbH
• Hannover, Germany
• 2 Divisions: Instrument Manufacturer – CRO
• CRO: Currently 4 phase I; 2 phase II trials
VA Partner
![Page 4: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/4.jpg)
Central Lab Services
4
Fully automated analyzer
24/7 operation
4,000 data points/week
“Spirit of GLP”
![Page 5: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/5.jpg)
Global Footprint
5
Sponsor
Central Lab BioBank ZellSafe™Box World Courier
![Page 6: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/6.jpg)
Case Study (opticus neuritis)
6
Clinical Neuroimmunology
![Page 7: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/7.jpg)
Clinical Neuroimmunology
7
- Disease: Multiple Scler.
- Study: Clinical
- Samples: 650
1. Round 2. Round
Outcome: - Stratification markers - Trial is ongoing
By courtesy of
![Page 8: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/8.jpg)
Work Flow
8
2. Load - Load sample, wait 5‘ - Fix (4% PFA), wait 15‘ - rinse, seal chip
1. Prep - 1 ml blood - CPT, Ficoll or RBC lysis - total time: 40’
3. Store - store on-site - temperature 4°C - up to several months
4. Ship GDP Logistics (Good Distribution Practice)
5. Bioanalysis “Spirit of GLP” clinical trial
support (SOP, QA)
6. Re-interrogate Test additional markers over >24 months
![Page 9: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/9.jpg)
Cell-based Biomarker Development
9
1: Study Preparation Phase
• SOP / Training Videos / Site Qualification
• On-site Training
2: Sample Collection Phase
• Custom kits with all consumables required
• Monthly / bi-monthly / quarterly sample pick-up according GDP
• Incoming sample QC and bio-banking analogous to GLP
3: Bioanalysis
• Assay / Method Development
• Method Validation analogous to GLP
• Sample analysis including ISR
• Option for sample re-interrogation for 24 months
4: Patient Stratification and Computational Biology
![Page 10: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/10.jpg)
Preparing Clinical Trials
Candidate Sites 1, 2, 3, 4,..
2. Site Qualification Kit
1. SOP, Training Video
10
![Page 11: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/11.jpg)
Collaborative Cytometry
Core Facility „Democratization“ Collaborate („go to an expert“) („have your own“) (“work with many”)
IT
FACS
11
![Page 12: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/12.jpg)
Biomarker Development
12
Clinical Research Center Hannover
Method Development • Preanalytics • Assay Development • Data Processing • Data Management
Pilot Preparation
Planning • Study plan / IPC • IRB • Clinical Database • Site Audit
Clinical trial
Execution • Study Coordinator • Data Collection • Sample Analysis • Sample Logistics • Biobanking
![Page 13: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/13.jpg)
Typical Milestone-based Project
13
Study Validation In-Study
Bioanalysis Work
Plan Panel Set-up
+ Controls
Samples Ideas
![Page 14: Chipcytometry in a clinical setting](https://reader034.fdocuments.in/reader034/viewer/2022042722/58aa539c1a28ab10578b5831/html5/thumbnails/14.jpg)
Thank you for your attention!
14
Selected Primary Publications
• Happle, Science Translational, 2014
• Dijkstra, Nature Medicine 2012
• Hennig, Br. J. Hematology 2010
• Woelbeling, Immunobiology 2011
• Polte, JACI 2008
System Validation according to:
• O'Hara, JIM 2011
• Green, JIM 2011
• Cunliffe, Pharm. Res. 2009
• Lee, Pharm. Res. 2006
• Bioanalytical Method Validation, FDA, 2013
“Precision Immunology” References
A B C Control Diseased Groups Group
Focus on: Translational Immunology Mode of Action(MoA) Patient Stratification Clinical Trial Support